← FDA Drug Approvals (Drugs@FDA)

ETOPOSIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA USA · Approved 2017-10-31

Drug application

FDA Application #

ANDA204927

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETOPOSIDE

Generic name

Etoposide

Active ingredients

ETOPOSIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

NATCO PHARMA USA

First approval

2017-10-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown